Emergent Medical Partners is a California-based life sciences venture capital firm focused on early-stage medical device and healthcare companies. Founded by Dr. Thomas Fogarty, the firm provides funding and expertise across the financial, medical, and engineering facets of medical device development.
30% of their portfolio is in Healthcare. Their most common stage is series-b (40% of deals). Average disclosed round size is $32.7M (across 9 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Standard Bariatrics | Series B | $35M | Jun 2021 |
| RReThink Medical | Series A | $3M | May 2017 |
 Chrono | Series B | $47.6M | Sep 2016 |
| CChrono Therapeutics | Series B | $47.6M | Sep 2016 |
| CChrono Therapeutics | Unknown | $47.6M | Jan 2016 |
 Focal Therapeutics | Series C | $3.8M | Aug 2014 |
 Arterys | Series C | $28M | — |
 Ardian, Inc. | Unknown | $47M | — |
| SStandard Bariatrics, Inc. | Series B | $35M | — |
| SStandard Bariatrics, Inc. | Series A | — | — |
Top Co-Investors
RiverVest Venture Partners3 shared
Asahi Kasei3 shared
Fountain Healthcare Partners3 shared
Cota Capital3 shared
Kaiser Permanente Ventures3 shared
Canaan Partners3 shared
Mayo Clinic Ventures3 shared
Endeavour Vision3 shared
LAUNCH1 shared
U.S. Venture Partners1 shared
QCA Ventures1 shared
Terra Venture Partners1 shared
Courtside Ventures1 shared
Revelation Partners1 shared
Fosun Group1 shared
Medtronic1 shared
Advanced Technology Ventures1 shared
Morgenthaler Ventures1 shared
Split Rock Partners1 shared
Last updated: 8 September 2026